LOS ANGELES, Jan. 27, 2025 /PRNewswire/ -- Partillion Bioscience Corporation ("Partillion"), a life science tools company, announced the opening of pre-orders for its Nanovial Multicell Assay Antibody ...
WOONSOCKET, R.I., July 11, 2011 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) ("MultiCell") today announced that it entered into a sponsored research agreement with ...
MultiCell Technologies, Inc. and Living Cell Technologies Limited (LCT) have announced that the parties have entered into a joint venture to develop therapeutic liver cell applications. The ...
MultiCell bases these forward- looking statements on current expectations about future events. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels ...
WOONSOCKET, R.I., Aug. 10, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the updated preclinical research results for MCT-465 and MCT-485. MCT-485 ...
Corporation gains the ability to use these assets for assay development, biomarker identification, and ADME/Tox. MultiCell Technologies entered into a worldwide, exclusive license and technology ...
WOONSOCKET, R.I., Aug. 6, 2013 -- /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) and Genisphere LLC will collaborate on the development of targeted MCT-485 nanoparticle ...
MultiCell Technologies, Inc. entered into a worldwide exclusive license and technology purchase agreement with Corning Incorporated of Corning, NY concerning the Company's Fa2N-4 immortalized adult ...
The Chianese Organometallic Chemistry group at Colgate University (Hamilton, NY, USA) are using a custom designed Multicell Parallel High-Pressure Reactor from Asynt to conduct reproducible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results